Lir Therapeutics

Lir Therapeutics is an early-stage biotechnology company redesigning adeno-associated virus capsids for gene therapy using an AI-first platform.

Its platform integrates high-throughput experimental data generation with machine learning models trained on structural, functional and immunogenicity representations of viral vectors.

The approach targets improvements in tissue specificity, delivery efficiency and immune evasion simultaneously, aiming to overcome key limitations of existing AAV gene therapy vectors.